Cargando…
Response to: Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
Autores principales: | Cao, Yuze, Wang, Jianjian, Zhang, Huixue, Tian, Qinghua, Chen, Lixia, Ning, Shangwei, Liu, Peifang, Sun, Xuesong, Lu, Xiaoyu, Song, Chang, Zhang, Shuai, Xiao, Bo, Wang, Lihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573091/ https://www.ncbi.nlm.nih.gov/pubmed/28884124 http://dx.doi.org/10.1155/2017/5359434 |
Ejemplares similares
-
Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis
por: Cao, Yuze, et al.
Publicado: (2015) -
Corrigendum to “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017) -
Identifying a Polymorphic ‘Switch’ That Influences miRNAs' Regulation of a Myasthenia Gravis Risk Pathway
por: Yang, Lili, et al.
Publicado: (2014) -
Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis
por: Li, Shuang, et al.
Publicado: (2019) -
Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis
por: Cao, Yuze, et al.
Publicado: (2017)